Cargando…
Genetic factors in pathogenesis of diabetes mellitus after kidney transplantation
Posttransplant diabetes mellitus (PTDM) is one of the major metabolic complications after transplantation of solid organs including the kidney. This type of diabetes mellitus affects allograft survival, cardiovascular complications and overall patient survival. The modifiable risk factors that contr...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388273/ https://www.ncbi.nlm.nih.gov/pubmed/28435278 http://dx.doi.org/10.2147/TCRM.S129327 |
_version_ | 1782521101575782400 |
---|---|
author | Tarnowski, Maciej Słuczanowska-Głabowska, Sylwia Pawlik, Andrzej Mazurek-Mochol, Małgorzata Dembowska, Elżbieta |
author_facet | Tarnowski, Maciej Słuczanowska-Głabowska, Sylwia Pawlik, Andrzej Mazurek-Mochol, Małgorzata Dembowska, Elżbieta |
author_sort | Tarnowski, Maciej |
collection | PubMed |
description | Posttransplant diabetes mellitus (PTDM) is one of the major metabolic complications after transplantation of solid organs including the kidney. This type of diabetes mellitus affects allograft survival, cardiovascular complications and overall patient survival. The modifiable risk factors that contribute to PTDM include obesity, some viral infections (eg, hepatitis C virus, cytomegalovirus) and especially immunosuppressive drugs including corticosteroids, tacrolimus, cyclosporine and sirolimus. Currently, predisposing genetic factors have been considered important in PTDM development. The commonly evaluated genetic determinants include genes encoding transcription factors, cytokines, chemokines, adipokines, ionic channels, glucose transporters, cytochrome P450 enzymes and other enzymes metabolizing drugs, drug transporters. Unfortunately, the results of studies are inconclusive and differ between populations. There is a need for large genome-wide association study to identify the genetic risk factors associated with PTDM development. |
format | Online Article Text |
id | pubmed-5388273 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-53882732017-04-21 Genetic factors in pathogenesis of diabetes mellitus after kidney transplantation Tarnowski, Maciej Słuczanowska-Głabowska, Sylwia Pawlik, Andrzej Mazurek-Mochol, Małgorzata Dembowska, Elżbieta Ther Clin Risk Manag Review Posttransplant diabetes mellitus (PTDM) is one of the major metabolic complications after transplantation of solid organs including the kidney. This type of diabetes mellitus affects allograft survival, cardiovascular complications and overall patient survival. The modifiable risk factors that contribute to PTDM include obesity, some viral infections (eg, hepatitis C virus, cytomegalovirus) and especially immunosuppressive drugs including corticosteroids, tacrolimus, cyclosporine and sirolimus. Currently, predisposing genetic factors have been considered important in PTDM development. The commonly evaluated genetic determinants include genes encoding transcription factors, cytokines, chemokines, adipokines, ionic channels, glucose transporters, cytochrome P450 enzymes and other enzymes metabolizing drugs, drug transporters. Unfortunately, the results of studies are inconclusive and differ between populations. There is a need for large genome-wide association study to identify the genetic risk factors associated with PTDM development. Dove Medical Press 2017-04-06 /pmc/articles/PMC5388273/ /pubmed/28435278 http://dx.doi.org/10.2147/TCRM.S129327 Text en © 2017 Tarnowski et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Review Tarnowski, Maciej Słuczanowska-Głabowska, Sylwia Pawlik, Andrzej Mazurek-Mochol, Małgorzata Dembowska, Elżbieta Genetic factors in pathogenesis of diabetes mellitus after kidney transplantation |
title | Genetic factors in pathogenesis of diabetes mellitus after kidney transplantation |
title_full | Genetic factors in pathogenesis of diabetes mellitus after kidney transplantation |
title_fullStr | Genetic factors in pathogenesis of diabetes mellitus after kidney transplantation |
title_full_unstemmed | Genetic factors in pathogenesis of diabetes mellitus after kidney transplantation |
title_short | Genetic factors in pathogenesis of diabetes mellitus after kidney transplantation |
title_sort | genetic factors in pathogenesis of diabetes mellitus after kidney transplantation |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388273/ https://www.ncbi.nlm.nih.gov/pubmed/28435278 http://dx.doi.org/10.2147/TCRM.S129327 |
work_keys_str_mv | AT tarnowskimaciej geneticfactorsinpathogenesisofdiabetesmellitusafterkidneytransplantation AT słuczanowskagłabowskasylwia geneticfactorsinpathogenesisofdiabetesmellitusafterkidneytransplantation AT pawlikandrzej geneticfactorsinpathogenesisofdiabetesmellitusafterkidneytransplantation AT mazurekmocholmałgorzata geneticfactorsinpathogenesisofdiabetesmellitusafterkidneytransplantation AT dembowskaelzbieta geneticfactorsinpathogenesisofdiabetesmellitusafterkidneytransplantation |